INTERNATIONAL PATENT: SANTEN PHARMACEUTICAL CO., LTD., 参天製薬株式会社 FILES APPLICATION FOR "SEPETAPROST-CONTAINING EYE DROP FOR LOWERING INTRAOCULAR PRESSURE DURING NIGHT SLEEP IN PATIENTS SUFFERING FROM GLAUCOMA OR OCULAR HYPERTENSION"

GENEVA, Aug. 5 -- SANTEN PHARMACEUTICAL CO., LTD. (4-20 Ofuka-cho, Kita-ku, Osaka-shi, Osaka5308552), 参天製薬株式会社 (大阪府大阪市北区大深町４番２０号) filed a patent application (PCT/JP2025/001974) for "SEPETAPROST-CONTAINING EYE DROP FOR LOWERING INTRAOCULAR PRESSURE DURING NIGHT SLEEP IN PATIENTS SUFFERING FROM GLAUCOMA OR OCULAR HYPERTENSION" on Jan 23, 2025. With publication no. WO/2025/159135, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed ...